{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6126, 
        6139
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6140, 
        6149
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6289, 
        6298
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6443, 
        6452
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6530, 
        6540
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6606, 
        6616
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6734, 
        6744
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6807, 
        6817
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6872, 
        6882
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6937, 
        6947
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7092, 
        7102
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7158, 
        7168
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5924, 
        5947
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9791, 
        9811
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5976, 
        6003
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6016, 
        6020
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9522, 
        9526
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6395, 
        6405
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6480, 
        6490
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6551, 
        6561
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6690, 
        6700
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6756, 
        6766
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6829, 
        6839
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6894, 
        6904
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6959, 
        6969
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7048, 
        7058
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7114, 
        7124
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9541, 
        9551
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9567, 
        9577
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9593, 
        9597
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9624, 
        9627
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9643, 
        9647
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9664, 
        9674
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9691, 
        9694
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9711, 
        9714
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9731, 
        9734
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9751, 
        9755
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9772, 
        9776
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        766, 
        795
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9358, 
        9393
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9435, 
        9461
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6184, 
        6207
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6517, 
        6540
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6593, 
        6616
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6721, 
        6744
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6794, 
        6817
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6859, 
        6882
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6924, 
        6947
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7019, 
        7042
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7079, 
        7102
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7145, 
        7168
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6278, 
        6288
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6432, 
        6442
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6659, 
        6665
      ]
    }
  ], 
  "Neoplasm Descriptive Grade (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6104, 
        6125
      ]
    }
  ], 
  "Neoplasm Grade Value (At)": [
    {
      "__agreement__": "FALSE POSITIVE", 
      "__annotator__": "Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7439, 
        7441
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6010, 
        6014
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6021, 
        6031
      ]
    }, 
    {
      "__agreement__": "FALSE POSITIVE", 
      "__annotator__": "Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7367, 
        7377
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9527, 
        9537
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9598, 
        9608
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6005, 
        6008
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6392, 
        6393
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6477, 
        6478
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6548, 
        6549
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6624, 
        6625
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6687, 
        6688
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6752, 
        6754
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6825, 
        6828
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6890, 
        6892
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6955, 
        6957
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7044, 
        7046
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7110, 
        7112
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9463, 
        9464
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9480, 
        9481
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9499, 
        9500
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9519, 
        9520
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9538, 
        9539
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9564, 
        9565
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9590, 
        9591
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9621, 
        9622
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9640, 
        9641
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9660, 
        9662
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9687, 
        9689
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9707, 
        9709
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9727, 
        9729
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9747, 
        9749
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        9768, 
        9770
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7176, 
        7193
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1053014^CLIA|eMARCPlus|TN Cancer Registry|20170919125826||ORU^R01^ORU_R01|201709191258260001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-21-008618^PathSys^44D1053014^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170825000000|||||||20170825000000|&Soft Tissue, other than tumor,mass,lipoma,debride, Soft Tissue, other than tumor,mass,lipoma,debride, Soft Tissue, other than tumor,mass,lipoma,debride, Lung, Total/Lobe/Segment Resection, Lymph Node|1205834777^^^^^^MD^^CMS^D^^^NPI||||||20170830000000|||F||||||C34.12^Malignant neoplasm of upper lobe, left bronchus or lung^I10~C77.1^Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes^I10|1821206962&&&E.&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\n1. Received fresh labeled with the patient's name \"\" and \"venous margin\" is a flattened segment of tissue showing a venous lumen branched into 3 branches. The specimen is 1.5 cm in area of greatest dimension. It is marked with blue ink and submitted entirely for histology, frozen and permanent sections. 2. Specimen #2 labeled with the patient's name \"\" and \"arterial margin\" is a membranous fragment of tissue 0.5 x 0.3 x 1.2 cm in overall dimensions. It is marked with red ink and submitted entirely for permanent and frozen sections. 3. Specimen #3 labeled with the patient's name \"\" and \"bronchial margin\" is a segment of bronchus 1.5 x 1.0 x 0.5 cm in overall dimensions. It is submitted entirely as received for frozen section along with specimens 1 and 2, but not inked. 4. Received fresh for frozen section is a left upper lobe of lung which shows a puckered subpleural mass. The pleural surface in the area of the mass is marked with blue ink. Sectioning reveals a cavitary irregular mass 5 cm in area of greatest diameter, approximately 2 cm from the hilar margin of the specimen. A representative section is submitted for frozen section of this mass. The specimen is non-crepitant, 203 g, 18 x 10 x 6 cm. There are multiple staple lines at the hilum. There are multiple tan-pink to red-brown anthracotic lymph nodes at the hilum. There are multiple vessels at the hilar margin ranging in diameter from 0.3 to 0.6 cm. The bronchus is in multiple branches which range in diameter from 0.6 to 0.8 cm. There are 3 lymph nodes at the hilum ranging in greatest dimension from 0.5 to 2.5 cm. The largest node has focal tan-white firm areas. Sectioning through the hilum reveals the underlying lesion is 1.3 cm from the margin of the resection of the bronchus. The wall of the bronchus is not grossly involved by the lesion. The lesion as previously described is at the pleural surface grossly. Representative sections are submitted as: A, 1 node, 2/1; B, representative section of the node with the nodules, 1/1; 1C, 1 node, M/1; 1D, multiple hilar vessels and bronchial margin, M/1; E, section of lesion with the pleural surface, 1/1; F, section of lesion with the closest bronchus, 1/1; G, H and I, sections of the lesion with surrounding parenchyma, all 1/1. (JH5/eh) 5. Received in saline labeled \", station 5 lymph node\" are 2 tan- pink to brown-black ovoid lymph nodes which range in size from 1.5 x 1 to 1.5 x 1.5 x 1 cm. Sectioning of each reveals brown-black anthracotic cut surfaces, each has a 0.3 x 0.5 cm in diameter soft, tan-white nodule. Representative sections of each node are submitted in separate cassettes. 1/1 each. (JH5/csb) 6. Received in saline labeled \", station 6 lymph node\" is a 2.5 x 1.2 x 0.6 cm brown-black anthracotic lymph node surrounded by a small amount of fibroadipose tissue. Sectioning of the node reveals brown-black anthracotic cut surfaces with no discrete nodules identified. The node is entirely submitted. M/1. (JH5/csb) 7. Received in saline labeled \", 12L lower lobe\" are 3 pieces of tissue, ranging in greatest dimension from 0.6 to 0.8 cm. Two of the tissue fragments are brown-black anthracotic lymph nodes, 1 piece is tan-yellow, soft, lobulated adipose tissue. One lymph node and the adipose tissue are submitted in A and the larger node is submitted in B. 2/1 each. (JH5/csb) 8. Received fresh labeled \", 4L\" is a 1.5 x 1 x 0.3 cm tan-yellow, soft, lobulated piece of fibroadipose tissue. Entirely submitted 1/1. (JH5/csb) 9. Recieved fresh labeled \", 10L node\" is a single tan-yellow possible lymph node measuring 0.5 cm in greatest dimension, submitted intact in cassette 9A. 1/1 10. Recieved fresh labeled \", subcarinal node\" are multiple pieces of adipose tisue and possible lymph nodes, the nodes are entirely submitted as A and B one node each, each 2/1, C the largest node M/1. 11. Received in saline labeled \", 8L\" is a 0.8 x 0.5 x 0.3 cm brown- black anthracotic lymph node surrounded by a small amount of tan-yellow soft lobulated adipose tissue. The specimen is entirely submitted. 3/1. 12. Received fresh labeled \", 9L\" is a tan-yellow soft lobulated piece of fibroadipose tissue with focal brown-black anthracotic tissue fragments. The specimen in aggregate is 1.2 x 0.5 x 0.3 cm. Entirely submitted. 1/1. 13. Received fresh in saline labeled \", 5L\" are multiple tan-yellow soft lobulated pieces of fibroadipose tissue which in aggregate are 2 x 1 x 0.3 cm. Also present is a possible tan-pink focally anthracotic lymph node which is 0.6 cm in greatest dimension. The adipose tissue is submitted in A, M/1; the possible node in B, 2/1. 14. Received fresh labeled \", 11L\" are 2 brown-black anthracotic lymph nodes surrounded by a small amount of tan-yellow soft lobulated adipose tissue. The nodes range in greatest dimension from 1.3 to 1.5 cm. Sectioning reveals no gross lesions. Each is submitted in a separate cassette, A, 2/1; B, 3/1. 15. Received fresh labeled \" 12L\" is a 0.6 x 0.4 x 0.3 cm tan-pink to brown-black anthracotic tissue fragment surrounded by a small amount of adipose tissue. The specimen is entirely submitted. 1/1. (JH5/DET/cc6)\n\n\nPath report.relevant Hx\n\nHistory - Left lung mass\n\n\nPath report.final diagnosis\n\n1-4. Lung, left upper lobe, resection with separate venous, arterial, and bronchial margins:       Poorly differentiated squamous cell carcinoma, 5 cm.       All surgical margins negative for malignancy.       Negative for pleural invasion (elastic stain evaluated).       Metastatic carcinoma in 2 of 3 hilar lymph nodes.       One negative intraparenchymal pulmonary lymph node (0/1). 5. Lymph node, station 5, excision:     Metastatic carcinoma in 2 lymph nodes (2/2). 6. Lymph node, station 6, excision:     Negative for malignancy (0/1). 7. Lymph node, 12L lower lobe, excision:     Negative for malignancy (0/2). 8. \"Lymph node\", 4L, excision:     Benign fibroadipose tissue. 9. Lymph node, 10L, excision:     Negative for malignancy (0/1). 10. Lymph node, subcarinal, excision:     Negative for malignancy (0/3). 11. Lymph node, 8L, excision:     Negative for malignancy (0/1). 12. Lymph node, 9L, excision:     Negative for malignancy (0/1). 13. Lymph node, 5L, excision:     Multiple lymph node fragments negative for malignancy. 14. Lymph node, 11L, excision:     Negative for malignancy (0/2). 15. Lymph node, 12L, excision:     Negative for malignancy (0/1). CANCER CHECKLIST: LUNG: Resection 2.004.001.1000043 SPECIMEN  Specimen: Lobe(s) of lung  Lobes of Lung: Upper lobe  Procedure: Lobectomy  Specimen Laterality: Left TUMOR  Primary Tumor Site: Upper lobe  Histologic Type: Squamous cell carcinoma  Histologic Grade: G3: Poorly differentiated  Tumor Size: Greatest dimension (cm)  Greatest dimension (cm): 5.0cm  Tumor Focality: Unifocal Tumor Extent  Visceral Pleura Invasion: Not identified  Tumor Extension: Not applicable Accessory Tumor Findings  Lymph-Vascular Invasion: Present, Lymphatic MARGINS  Uninvolved Margins: All margins uninvolved by invasive carcinoma  Distance of Invasive Carcinoma from Closest Margin: Specify (mm)  Specify (mm): 13mm  Margin Closest to Invasive Carcinoma: Specify margin  Specify margin: bronchial  Bronchial Margin: Uninvolved by invasive carcinoma and carcinoma in situ  Vascular Margin: Uninvolved by invasive carcinoma  Parenchymal Margin: Uninvolved by invasive carcinoma  Number of Lymph Nodes Examined: At least  At least: 19  Nodal Stations Examined: 7: Subcarinal, 5: Subaortic/ aortopulmonary (AP) / AP window, 6: Para-aortic (ascending aorta or phrenic) , 8L: Para-esophageal, 9L: Pulmonary ligament, 10L: Hilar, 11L: Interlobar, 12L: Lobar  Number of Lymph Nodes Involved: Specify number  Specify number: 4  Nodal Stations Involved: 5: Subaortic/ aortopulmonary (AP) / AP window, 10L: Hilar STAGE (pTNM)  TNM Descriptors: Not applicable  Primary Tumor (pT): pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus); or Tumor 5 cm or less in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung  Regional Lymph Nodes (pN): pN2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph nodes  Distant Metastases (pM): Not applicable - pM cannot be determined from the submitted specimen(s)\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.site of origin\n\n1. Venous margin 2. Arterial margin 3. Bronchial margin 4. Left upper lobe 5. Station #5 - permanent 6. Station #6 - permanent 7. 12 L Lower Lobe - permanent 8. 4 L - permanent 9. 10 L - permanent 10. Subcarinal - permanent 11. 8 L - permanent 12. 9 L - permanent 13. 5 L - permanent 14. 11 L - permanent 15. 12 L - permanent\n\n\nPath report.comments\n\nComments - The case is reviewed in conjunction with results from 17-21-8604.\n\n\n"
}